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Melanoma in children is rare. Nevertheless, it is imperative 
that clinicians be aware that melanoma does occur in childhood. 
Yet there is very little information available on the clinico- 
pathologic variations, and the prognostic parameters of mela­
noma in children. This report presents the results of a multicenter 
study of 102 lesions originally diagnosed as cutaneous melanoma, 
conducted among 5 Western European countries and collected 
during the period 1961-1994. Criteria for inclusion in the study 
included: ( I)  diagnosis of cutaneous melanoma; (2) age up to 16 
years at diagnosis; and (3) availability of representative microscopic 
slides. On the basis of the histologic review only, 60 lesions were 
confirmed as melanoma, and 42 lesions initially diagnosed as mela­
noma were reclassified as nevi; 31 of the latter contained a 
predominance of spindle cells. The only significant parameter 
associated with the development of metastases or fatal outcome 
was thickness of more than 2.00 mm. The 5-year survival rate 
observed in this study was 84%. Based on these findings we 
conclude that considerable over-diagnosis of melanomas in children 
occurs. In order, therefore, to give consistent epidemiological data 
on melanomas in children and to improve proper recognition of 
their diagnostic features, both by clinicians and by pathologists, we 
propose to set up a central registry of melanomas in children in 
Europe, under the auspices of the European Organization for 
Research and Treatment of Cancer.
© 1996 Wiley-Liss, Inc.
The incidence of melanoma has been steadily increasing 
worldwide, at an average rate of 4 to 6% per year (Ries et a l} 
1991) and has been noted as rising faster than all other types of 
cancer. It now constitutes around 3% of all malignant diseases. 
Adults in all age groups are affected, with a reported world­
wide average age at diagnosis of 48 years (Balch, 1992). 
Children are rarely affected. Despite this rarity, it is imperative 
that clinicians be aware that melanoma does occur in child­
hood. However, there is very little information available on the 
clinico-pathologic variations, and the prognostic parameters of 
malignant melanoma in children. Difficulties in investigation 
of this subject are multiple: there are few series with adequate 
follow-up; criteria for inclusion in the published studies are 
heterogeneous; the histologic criteria established for the 
recognition of melanoma in adults are not absolutely appli­
cable to those of children; and, finally, the histo-prognostic 
parameters used in adults have not been validated in children. 
Thus, many authors have pointed out the necessity of a large 
multicentre study on melanoma in children.
In order to provide criteria which may be of help in the 
diagnosis and treatment of childhood melanoma, we have 
conducted a multicenter study in institutions that provide 
members of the EORTC-Melanoma Cooperative Group. In 
the present paper, we examine the clinico-pathological fea­
tures of 102 cases referred to our institutions as childhood 
melanoma between 1961 and 1994.
MATERIAL AND METHODS
Design
Cases were all the patients for whom a diagnosis of cutane­
ous melanoma had been made before their 17th birthday and
from whom a representative slide of the lesion was available in 
one of the collaborating centers. This included cases with 
congenital nevi and xeroderma pigmentosum. The cases were 
collected during the time period 1961-1994, which represents 
the range of earliest and latest reports. The following institu­
tions constituted the study group: Institut Gustave-Roussy, 
Villejuif, France (34 cases); University Hospital, Nijmegen, 
The Netherlands (31 cases); Institut Jules Bordet, Brussels, 
Belgium (16 cases); Kantonsspital, Münsterlingen, Switzer­
land (11 cases); Hôpital Henri-Mondor, Créteil, France (9 
cases); Hautklinik der Universität, Würzburg, Germany (3 
cases); Centre Léon-Bérard, Lyon, France (2  cases); and 
Universiteit Gent, Gent, Belgium (1 case). The Dutch cases 
came from a national registry representing complete popula­
tion coverage. The other slides were from children followed in 
the center or referred to the center due to difficulty in making a 
diagnosis. About 50 cases would have been eligible for inclu­
sion, but had to be excluded because no slides were available 
for review.
Clinical parameters
Clinical variables included date of birth, age at diagnosis, 
sex, localization, clinical diagnosis, associated cutaneous mela- 
nocytic lesion, treatment, date of first recurrence, date of last 
follow-up information, and vital status. Family history of 
melanoma was defined as histologically confirmed melanoma 
diagnosed in 2 family members. The stage at diagnosis was 
classified according to Schultz and Mastrangelo (1989). Apart 
from the family history of disease in patients followed at the 
Institut Gustave-Roussy, which was collected directly from 
patients by a research team, all these data were collected from 
routine clinical records.
Pathologic parameters
The slides were reviewed by a panel of 7 pathologists (A.S., 
D.R., T.H., N.R., J.W., C.B., M.P.). All the panel members 
reviewed all the slides. In the great majority of cases, panel 
members were not involved in making the original diagnoses. 
This review was made with no knowledge of the clinical 
outcome, and resulted in classification into 2 groups: a group 
of lesions initially diagnosed as melanoma and reclassified as 
such by the reviewing group, and a group of lesions initially 
diagnosed as melanoma but reclassified as nevus. Panel mem­
bers were aware of how the other reviewers scored the slides.
10To whom correspondence and reprint requests should be sent, at 
Department of Pathology, Institut Gustave-Roussy, 94805 Villejuif 
Cedex, France. Fax: 145 59 63 81.
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’"EORTC-MCG is the acronym for the European Organization for 
Research and Treatment of Cancer-Melanoma Cooperative Group,
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TABLE I - MALIGNANT MELANOMA !N CHILDHOOD
Case Gender
Age
(yrs) Site Stage
Predispo­
sition
Size
(mm) Type
Thickness
(mm)
Clark’s
level
Mitotic
index
(/HPF)
Ulceration
Extension 
(location/ mths)
Follow- up 
(mths)
Status
1 F 13 Leg III 0 7 SSM1 3.5 III 0.2 Y lymph node, 
skin/0
4 DOD
n M 8 Ankle 1 0 6 NM1 3,05 IV 0.2 0 0 22 FOD
3 F 7 Thigh I 0 5 SSM 3.4 IV 0.1 Y 0 136 FOD, rhabdo.
4 M 5 Thigh I 0 6 SSM 3 IV 1.4 0 lymph node/9 80 FOD
5 F 6 Trunk I CN 20 SSM 15 V 0.3 NA lymph node/7 107 FOD
6 M 10 Heel II 0 20 ALM 2,5 III 0.2 NA lymph node/0 7 AWD
7 M 9 Knee I 0 10 SSM 2.3 III 0.4 0 0 0 LFU
8 F 14 Back I 0 5 SSM 0.9 III 0.2 0 0 90 FOD
9 M 16 Back I N 11 SSM 2.94 IV 0.8 Y skin/3 78 DOD
10 M 14 Heel II 0 7 ALM 3.93 IV 0.1 0 skin / 8 13 DOD
11 F 6 Thorax II FM 10 NM- 5.1 IV 0.8 Y lymph node/0 
+ 108; bone/168
172 DOD
12 M 6 Arm I 0 3 SSM1 4.12 V 0.1 NA lymph node/12 FOD
13 F 16 Back I FM 6 SSM 0.38 III 0 0 0 44 FOD
14 F 14 Back I N 10 U 4 IV 0.1 Y NA 21 DOD
15 M 1 Scalp I CN 10 u 1.8 III 1 0 0 60 FOD
16 M 12 Arm II 0 15 u 10 V 0.9 Y NA/8 19 DOD
17 F 13 Back I CN 6 SSM 0.85 III 0.1 0 0 12 FOD
18 F 14 Thigh I 0 10 SSM2 4.32 IV 0.4 Y lymph node/60 328 FOD
19 F 2 Scalp I 0 6 U2 3 IV 0.1 Y NA 24 FOD
20 F 7 Arm I 0 5 SSM3 2 IV 1 0 0 92 FOD
21 F 11 Leg I 0 7 SSM 1.5 IV 0.1 0 0 74 FOD
22 F 14 Back I 0 7 SSM 1 III 0.6 0 0 36 FOD
23 M 7 Shoulder I 0 8 NM5 4 IV 3 0 0 84 FOD
24 F 14 Thorax I 0 18 SSM2 1.35 III 0.4 0 0 102 FOD
25 M 12 Back I 0 7 SSM2 1.6 III 0 0 0 120 FOD
26 F 8 Shoulder I 0 4 SSM 0.9 III 0.1 0 0 96 FOD
27 F 12 Thigh II 0 6 SSM 4 III 0.4 0 lymph node/0 144 FOD
28 M 11 Cheek I 0 8 SSM 2.75 IV 3.3 Y lymph node/12, 
skin/39, 
pulm/39
39 DOD
29 M 13 Back I 0 6 U 3.35 IV 0.1 0 0 96 FOD
30 M 9 Sole NA 0 13 u 2.6 IV 0.7 Y NA 0 LFU
31 M 6 Leg I 0 10 SSM3 10 V 0.8 Y 0 2 FOD
32 M 1 Scalp I CN 7 SSM 4.8 III 0.6 Y 0 78 FOD
33 F 8 Nose I XP 15 SSM 0.39 II 0.4 0 0 89 FOD, thyroid 
carc. with lung 
métastasés
34 M 8 Thigh II 0 5 NM 4.71 V 1 0 lymph node/0 117 FOD
35 M 13 Toe I 0 NA SSM 2.80 IV 0.3 0 lymph node/20 44 FOD
36 M 14 Thigh I NA NA SSM NA NA NA NA NA 0 LFU
37 M 14 Leg I 0 6 SSM 1.57 III 1 0 lymph node/50 57 FOD
38 M 16 Back I N 7 SSM 1.88 III 13 0 lymph node/4; 
skin, lung/22
39 AWD
39 F 9 Thigh I N 5 SSM 1.84 IV 8 Y 0 16 FOD
40 M 12 Thorax I N 6 NM 2.16 IV 0.3 0 0 7 FOD
41 F 11 Thorax I 0 7 U 5.1 V 5.3 0 skin / 7 7 AWD
42 F 16 Back I N NA NM 2.16 III 0.3 Y NA 0 LFU
43 M 13 Thigh I 0 4 SSM2 0.88 III 0 Y 0 112 FOD
44 F 14 Shoulder I 0 6 U 2.18 IV 0 0 0 53 FOD
45 F 8 Knee I 0 11 U 11 V 1 Y 0 5 FOD
46 M 9 Scalp I 0 8 U 4 IV 0 Y lymph
node/4 + 28
120 FOD
47 F 10 Back I N 4 u 1.57 IV 0.1 0 0 131 FOD
48 F 16 Arm I 0 8 SSM 0.52 II 0 0 0 13 FOD
49 M 16 Back I 0 5 SSM 0.84 III 0 0 NA 0 LFU
50 M 13 Back I 0 3 u 6.68 III 4.6 Y liver/12 84 FOD
51 M 15 Back I 0 7 SSM 0.88 III 1 0 0 70 FOD
52 F 15 Thigh I 0 12 NM1 1.96 III 0.1 0 NA 0 LFU
53 M 15 Leg I 0 6 NM 3.34 III 1.6 Y NA 0 LFU
54 F 16 Leg I 0 9 SSM 1.11 III 0.2 Y 0 1 FOD
55 M 6 Cheek I XP NA U 1.96 IV 0 Y 0 8 Dead, SCC
56 F 10 Eyelid I XP 3 U 0.98 III 0.7 Y NA 0 LFU
57 F 4 Cheek I XP NA SSM 0.23 II 0 0 0 2 FOD, SCC
58 F 4 Scalp I XP 3 SSM 0.2 II 0 0 0 2 FOD, SCC
59 M 7 Ear I 0 8 NM1 3.34 IV 0.2 Y 0 36 FOD
60 F 16 Leg I 0 4 SSM 1.32 IV 0.1 0 NA 0 LFU
. HPF, high-power field; NA, not available; CN, congenital naevus; N, other nevus; FM, familial melanoma; XP, xeroderma
pigmentosum; SSM, superficial spreading melanoma; NM, nodular melanoma; ALM, acral lentiginous melanoma; U unclassified* Y
yes; pulm., pulmonar; rhabdo., rhabdomyosarcoma; DOD, dead of disease; FOD, free of disease; AWD, alive with disease; LFU, lost to
follow-up, care., carcinoma, SCC, spino-cellular carcinoma.—^Spitz-nevus variant.—2Prominent component of monomorphous small 
cells.-3Deep-penetrating nevus variant.
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However, when responses were discordant (30 cases), the 
diagnosis was made by consensus. The lesions confirmed as 
melanoma were classified according to the international classi­
fication of melanoma (McGovern et a l, 1973), and then to 
Clark’s anatomical levels. The tumor thickness was measured 
by micrometer according to Breslow. For all lesions, the other 
pathological features evaluated included size, mitotic rate per 
10 fields using a x40 objective (HPF), location of mitoses, 
presence and size of ulceration, features of inflammatory 
regression, evidence and nature of associated lesion, symmetry 
of lesion, evidence and location of ascension into the epider­
mis, demarcation of the borders, maturation, location and type 
of melanin, cellular appearance, type of cells, nuclear abnor­
malities, inflammatory infiltrate and microscopic details of 
excision margins. The cases reviewed included 13 reported 
earlier (cases 1-13; Lartigau e ta l, 1995).
Analysis
All cases were entered into a computerized data base, using 
the EPI INFO 6 software (Centers for Disease Control and 
Prevention, USA). Comparisons of melanoma and nevi pa­
tients used Chi-squared tests for qualitative variables and the 
Wilcoxon 2-sample test for quantitative variables. Comparison 
of the age distribution for the different tumoral sites used the 
Kruskal-Wallis test. Overall survival was assessed using Kaplan- 
Meier estimates. The univariate analysis of risk factors for 
metastasis or death used the log-rank test (Peto and Peto, 
1972). Multivariate survival analysis was performed with a Cox 
proportional-hazard model (Cox, 1972).
RESULTS
The clinical and pathologic findings of the 102 cases histologi­
cally reviewed are presented in Tables I and II. On the basis of 
this review, 60 lesions were classified as melanoma. Forty-two 
lesions initially diagnosed as melanoma were reclassified as 
Spitz nevus (6 cases), atypical Spitz nevus (5 cases), Reed 
nevus (11 cases), congenital-type nevus (4 cases), halo nevus (2 
cases), deep-penetrating nevus (1 case) and other types of 
nevus (13 cases).
Table III compares the histologic features of the lesions 
reviewed as melanoma with those reviewed as nevus. Con­
firmed melanomas were larger (i.e., > 1 mm), and more often 
presented ulceration, high mitotic activity (>5 mitoses/10 
HPF), mitoses in the lower third of the lesion, epitheloid 
melanocytes, asymmetry, lateral borders not well demarcated, 
lack of maturation, dusty melanin, and marked nuclear poly­
morphism. A predominance of spindle cells indicated a nevus; 
thus, 31 lesions (74%) initially diagnosed as melanoma but 
reviewed as nevus contained spindle cells. Thirty-five (59%) 
melanomas were superlicial-spreading melanomas (SSM), dis­
playing a prominent pagetoid intra-epidermal component. 
Nine (16%) melanomas were nodular (NM). Two cases (cases 
6 and 10), involving the heel in Caucasian patients, had a 
lentiginous intra-epidermal component. Another case (case 
55), diagnosed in a patient with xerodema pigmentosum, was 
similar to lentigo malignant melanomas diagnosed in elderly 
patients. Six cases were characterized by a prominent compo­
nent of monomorphous small cells, containing basophilic 
round nuclei, reminiscent to those of a lymphoma or a 
melanocytic nevus (Fig. 1). Five cases were Spitz-nevus vari­
ants. These tumors were composed of epitheloid or spindle 
cells resembling the cells in Spitz nevi. There were only few 
mitoses (1 to 2 mitoses/10 HPF), but they were located in the 
deep part of the lesion, and the cells exhibited marked nuclear 
atypia (Fig. 2). Three melanomas resembled deep-penetrating 
nevus by their extension into the deep dermis or fat and by a 
large nevic cell type with pigment synthesis through the full 
thickness of the lesion (Fig. 3). In these lesions, mitoses were 
frequent (8 to 30 mitoses/10 HPF) and deeply situated. In 
59 melanomas, the mean thickness was 3.00 mm, with a 
range of 0.20 mm to 15 mm; 39 cases (66%) were thicker than 
1.50 mm.
Table IV summarizes the clinical features of the melanomas 
in comparison with those of the lesions reclassified as nevus. 
The patients ranged in age from 1 to 16 years, with a mean age 
for patients with melanoma of 10.4 years, not significantly 
different from those of patients with nevus. In the 2 groups, 
gender was equally distributed. There was no significant 
correlation between the localization and the final diagnosis. 
Age at diagnosis varied with site: patients with head and neck 
melanoma were the youngest, patients with trunk and lower- 
Iimb melanoma were the oldest, and those with upper-limb 
melanoma were at an intermediate age (p < 0.001). Eighteen
TABLE II - NEVI IN CHILDHOOD, ORIGINALLY DIAGNOSED AS MELANOMA
Case Gender
Age
(yrs)
Site Type
61 M 14 Sole Common
62 M 11 Arm Halo-nevus
63 F 13 Foot Congenital
64 M 14 Thigh Common
65 F 13 Leg Atypical Spitz
66 M 15 Arm Reed
67 M 16 Foot Common
68 M 16 Back Atypical Spitz
69 M 16 Back Common
70 F 6 Palm Spitz
71 M 11 Back Common
72 F 2 Leg Atypical Spitz
73 F 12 Thigh Spitz
74 M 15 Thigh Atypical Spitz
75 M 14 Back Congenital
76 M 16 Leg Spitz
77 F 10 Shoulder Reed
78 M 13 Back Spitz
79 M 8 Toe Common
80 F 15 Thorax Common
81 F 14 Thigh Atypical Spitz
Follow-up
(months)
Status Case Gender
Age
(yrs)
Site Type
Follow-up
(months)
DPN, deep-penetrating nevus; FOD, free of disease; LFU, lost to follow-up.
Status
5 FOD 82 F 13 Scalp Reed 0 LFU
4 FOD 83 F 16 Back Spitz 1 FOD
1 FOD 84 F 7 Arm Reed 0 LFU
1 FOD 85 M 13 Back Congenital 95 FOD
39 FOD 86 F 6 Leg Reed 114 FOD
5 FOD 87 F 13 Arm Reed 76 FOD
4 FOD 88 M 11 Leg Reed 108 FOD
1 FOD 89 F 9 Back Spitz 110 FOD
4 FOD 90 F 14 Leg Common 0 LFU
2 FOD 91 M 11 Foot Congenital 72 FOD
77 FOD 92 M 2 Cheek Common 104 FOD* T 
28 FOD 93 F 1 Scalp Common 0 LFU
0 LFU 94 M 5 Cheek Common 95 FOD
39 FOD 95 F 7 Trunk Reed 0 LFU
0 LFU 96 M 10 Forearm DPN 89 FOD
30 FOD 97 F 11 Thorax Halo-nevus 0 LFU
0 LFU 98 F 4 Forearm Reed 74 FOD
0 LFU 99 F 10 Thigh Reed 0 LFU
9 FOD 100 M 11 Leg Common 0 LFU
66 FOD 101 M 11 Eyelid Reed 140 FOD
41___ FOD 102 M 12 Abdomen Common 54 FOD
l st t  f ll .
SPATZ £T/1 L.
TABLE III - MAIN PATHOLOGIC FEATURES OF MELANOMAS AND NEVI1 IN CHILDHOOD
Feature
Percentage
Melanoma (n = 60) Nevus (n = 42)
p value
Size
Mean 8.1 mm 5.4 mm <0.001
Histologic sub-types
59
-- -
SSM
ALM 1
Unclassified radial growth phase 3
NM 16
Unclassi fiable 21
Thickness (mm)
3.01 (0.20-15)
-------
Mean (range)
<0.75 mm 10
0.76-1.50 mm 24
1.51-3.00 mm 29
>3.00 mm 37
Clark level —
I 0
II 7
III 41
IV 41
V 11
Ulceration
<0.001Present 56 12
Mitotic rate (/10 HPF)
0.87 (0-11) <10-«Mean (range) 6.23 (0-53)
<5 46 93
5-10 34 5
>10 20 2
Cell type
0Epitheloid 37 CIO"5
Spindle 17 50
Small 22 26
Mixed, epitheloid and spindle 24 24
Regression
0 NSPresent 2
Symmetry
67 0.01Present 38
Epidermal spread
9 24 NSNone
In the center 33 38
In the borders 4 0
Both 54 38
Lateral borders
Well demarcated 28 55 0.01
Maturation
Present 2 67 <10-6
Melanin
None 16 7
Coarse 12 71 CIO“6
Dusty 9 2
Both 63 19
Nuclear polymorphism
7None 43
Slight or moderate 51 50
Marked 42 7 A o 1 O
'
Inflammatory reaction
Present 49 74 NS
Excision
Complete 69 83 NS
•Originally diagnosed as melanoma, but after review classified as nevus.-NS, not significant; SD, 
standard deviation.
patients (30%) with melanoma had an associated condition. 
These included xeroderma pigmentosum in 5 cases, a family 
history of melanoma in 2 cases. In 11 cases (18%) the 
melanoma arose on a nevus, of congenital type in 4 cases (6%). 
Another patient (case 3) had a personal history of rhabdomyo­
sarcoma diagnosed at 5 years of age and treated by surgical 
excision, chemotherapy (6 courses of vincristine, actinomycin 
and cyclophosphamide), and external radiotherapy (45 Gy). 
The melanoma appeared 2 years later on the border of the
irradiated area. Fifty-two patients (88%) with melanoma had 
localized disease (Stage I) at presentation, while 6 patients 
(10%) had regional metastases (Stage II), and one patient had 
disseminated disease (Stage III). Nine patients (cases 1, 5, 10,
12, 14, 16, 35, 38, 50) received systemic chemotherapy for 
metastatic disease. One patient (case 4) received adjuvant 
chemotherapy at the time of diagnosis. A regional lymph-node 
metastasis appeared 9 months after diagnosis. One patient 
(case 76), with a lesion reviewed as nevus, had received
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F igure  1 - Small-cell melanoma. The dermis contains areas of small nevus-like cells that are monomorphous, with lack of maturation 
(case 18, H&E, scale bar, 0.8 mm). Insert; Some nuclei are hyperchromatic, while mitoses are present in the deep part of the lesion.
immunotherapy. This patient was in good health 30 months 
after diagnosis.
Among 60 patients with melanoma, follow-up ranged from 0 
to 27 years (mean: 5 years). Nine patients had no follow-up. 
Forty-one patients (68%) were followed up for more than one 
year. Twenty (39%) of the 51 patients with follow-up have had 
metastases. Seven of these died of their disease, including one 
patient (case 11) who died with multiple metastases 14 years 
after the diagnosis, 3 were alive with melanoma, and 10 were 
free of disease after 44 to 328 months to follow-up (mean: 115 
months). Thirty-one patients remained free of disease, with 
follow-up duration of 5 years or more for 20 patients. The 
5-year survival rate is 84%. The only statistically significant 
parameter associated with the development of metastases or 
fatal outcome was a thickness of more than 2.00 mm 
(p  < 0.001). At 5 years, disease-free rates were 81% [confi­
dence interval (Cl), 71-91%] for patients with melanoma up to 
2.00 mm thick, and 28% (Cl, 18-38%) for those with mela­
noma more than 2.00 mm thick. There was no difference in 
prognosis among lesions of Clark’s level II or III and those of 
Clark’s level IV or V (p  = 0.15), or between males and females 
(p  = 0.09). A multivariate-suivival analysis confirmed these results 
(Table V). There was no recurrence in 30 patients with a benign 
lesion who were followed up for one month to 11 years (mean: 49 
months). Twelve patients with nevus had no follow-up.
DISCUSSION
Melanoma is rare in childhood, less than one percent of 
melanomas occurring in patients under the age of 17 years
(Urist and Hynds Karnell, 1994). In Queensland, the age- 
adjusted incidence for children aged 0 to 14 was nearly 
10/million children/year, compared with age-adjusted inci­
dence rates of 666/million in adult males and 564/million in 
adult females (Whiteman et a i, 1995). Because of this rarity, 
only a limited number of cases have been reported and, in 
several of those series, the lesions have not been subjected to 
histopathologic review. Moreover, follow-up is often missing. 
This report presents the results of a retrospective multicenter 
study of 102 lesions originally diagnosed as cutaneous mela­
noma conducted among 5 Western European countries.
Mackie et a l (1991), in a study of 95 patients below 30 years 
of age have shown a survival advantage for females. They 
suggested a phenotypic rather than an acquired characteristic. 
The fact that, in the present series of patients aged 0 to 16, 
melanomas in males carry the same prognosis as in females 
suggests that the prognostic value of gender appears later in 
life. The site distribution of the melanomas was similar to 
those of the nevi, whatever the gender, the lower limb being 
the most frequent site. Genetic and congenital predisposition 
to the development of melanoma include xeroderma pigmento­
sum, family history of melanoma, congenital nevi and dysplas- 
tic nevi. In addition, immunosuppression can be considered as 
such. Five patients in our series had xeroderma pigmentosum; 
they were less than 10 years old and developed melanoma on 
the head; 3 of them had also spino-cellular carcinomas at 
diagnosis, leading to death in one patient. Two patients with 
melanoma came from melanoma-prone families. Novakovic et 
a l (1995), in studying 23 melanoma-prone families, showed
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F igure  2 - Spitz-like melanoma. This lesion exhibits overall symmetry, deeply infiltrating proliferation, with a cellular nodule in the 
upper dermis (cases 2, H&E, scale bar, 0.6 mm). Insert: High magnification showing discohesive population of large cells with 
ground-glass pinkish cytoplasm; nuclei are pleomorphous.
that a family history of melanoma and the presence of 
dysplastic nevi identify children with a high risk of melanoma 
developing at an early age. Among 125 patients below 20 years 
of age at the time of first clinical evaluation, they observed 5 
invasive melanomas in 4 patients diagnosed before the age of 
17 years, all of them occurring within a precursor nevus. 
Although it has been stated that one third of prepubertal 
melanomas arose in large congenital nevi, this notion has been 
disputed. In our series, only 4 melanomas arose in a congenital 
nevus; they were diagnosed at one year of age in 2 patients, at 6 
years of age in another, and at 13 years of age in the fourth 
patient. If the frequency of malignant transformation in 
congenital nevi is presumed to be less than 5% (Kopf et a l, 
1979), half the cases of melanoma within congenital nevi occur 
in the first decade of life (Ruiz-Maldonado et a l, 1992). Thus, 
when prophylactic removal of congenital nevi is decided, it 
should be done in early life.
The histopathologic diagnosis of melanoma in children is 
difficult because of the occurrence of histologic simulators of 
melanoma such as atypical Spitz tumors and atypical areas 
developing in congenital nevi. The fact that 40% of lesions 
initially diagnosed as melanoma were reclassified after review 
as nevus in our series illustrates the difficulty in diagnosing 
childhood melanoma. Nevertheless, most studies have empha­
sized the necessity for earlier recognition of melanoma in 
children and adolescents (Ceballos et a l, 1995). This is 
supported in the present series by the observation that 66% of 
the melanomas were thicker than 1.5 mm. Since the initial 
description of the Spitz nevus by Spitz (1948), the distinction
between melanomas and Spitz nevi is still one of the most 
difficult problems in pathology and may lead in quite a few 
instances to over-diagnosis of melanoma. On the other hand, 9 
melanomas associated with death or widespread metastases 
and initially diagnosed as Spitz nevi have been reported in the 
literature (Spitz, 1948; Boddie et a l, 1978; Peters and Goell- 
ner, 1986; Crotty et a l, 1992; Mehregan and Mehregan, 1993; 
Tate et a l, 1993; Barnhill et a l, 1995). The case reported by 
Barnhill et a l (1’995) was fairly symmetric and had a low 
mitotic rate. In the present study, 5 patients had Spitz-like 
melanoma (cases 1, 2, 12, 52, 59). Two of them developed 
metastases, leading to death in one patient. All of these lesions 
were characterized by deep mitoses, marked nuclear atypia 
and high cellularity. Despite their particular pathologic presen­
tation and the difficulty in distinguishing them from Spitz nevi, 
more studies with adequate follow-up are needed before 
placing these lesions in a separate category. Eleven lesions 
were reclassified as pigmented spindle-cell Reed nevi, because 
of the presence of nests of large melanin-containing spindle 
cells in a heavily pigmented sharply demarcated lesion contain­
ing occasional mitoses. It is noteworthy that 31 lesions initially 
diagnosed as melanoma but after review classified as nevus 
contained a predominance of spindle cells. None of these 
lesions has recurred. As noted by Smith (1987), spindle-cell 
nevi represent a clinico-pathologic spectrum which is too often 
misdiagnosed as melanoma. In several studies, it was suggested 
that tumor thickness was of less prognostic value in children 
than in adults. Our data do not support this viewpoint, since 
tumor thickness appeared to be the best prognostic indicator.
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F igu re  3 - Nodular melanoma with features of deep penetrating nevus. This lesion shows a dome-shaped surface, overall symmetry, 
and an extension into the deep reticular dermis. Cells are tightly p>acked in nests and fascicles (cases 23, H&E, scale bar, 0.8 mm). Insert: 
Pigmented spindle cells with cytologic atypia and high mitotic activity.
TABLE IV - MAIN CLINICAL FEATURES OF MELANOMAS AND NEVI1 IN
CHILDHOOD
Percentage
Feature ---------------------------------
Melanoma (n = 60) Nevus (n = 42)
Age
Mean 10.4 years 11 years
Range 1-16 years 1—16 years
<5 years 10 12
6-10 years 35 21
11-16 years 55 67
Gender
Female/Male 1 0.9
Site
Head/neck
(RTD2) 
18 (1 .63
(RTD2) 
12 (1.09)
Trunk 32(1) 29 (0.90)
Upper limb 12(0.63) 19 (1)
Lower limb 38 (1) 40 (1.05)
JOriginalIy diagnosed as melanoma, but after review classified 
as nevus.-2Relative tumor density = proportion of tumors occur­
ring at site divided by proportion of total body-surface area 
occupied by that site.
In conclusion, the diagnosis of melanoma in children has to 
be assessed extremely carefully, since some benign lesions, i.e., 
atypical Spitz nevi and pigmented spindle-cell nevi, have very 
similar histologic features. On the other hand, since tumor 
thickness is the prevailing prognostic parameter, early diagno­
sis of melanoma in this population of patients also should be 
made. It has been suggested in literature that melanoma in
TABLE V - UNIVARIATE ANALYSIS AND MULTIVARIATE COX 
REGRESSION MODEL FOR DISEASE-FREE SURVI VAL: ALL PATIENTS
Parameter
Univariate Multiva riate
R R 1 Cl2 p value R R 1 Cl2 p value
Thickness
<2 mm 1 <0.001 1 0.007
>2 mm 6.2 [1.8-21.2] 7.3 [1.70-31.74]
Gender
Female 1 NS 1 NS
Male 2 [0.8-5.1] 1.3 [0.50-3.42]
Cl ark Ievel
II or III 1 NS 1 NS
IV or V 1.9 [0.7-5] 1.48 [0,48-4.53]
Relative risk of metastasis or death.~295% confidence interval 
of relative risk.
children is associated with a poorer prognosis than in adults 
(Mehregan and Mehregan, 1993). The 5-year survival rate 
observed in our study is 84%, which is higher than that in adult 
patients when matched for thickness (Balch, 1992). However, 
prospective studies of melanoma in children and related 
atypical nevi need to be carried out in order to give consistent 
epidemiological data and to increase recognition of relevant 
diagnostic features, both by clinicians and pathologists. For 
this purpose, we propose to set up in Europe a central registry 
of melanomas in children, under the auspices of the EORTC 
Melanoma Cooperative Group.
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